In 2025, Hims jumped on the GLP-1 craze, partnering with Novo Nordisk for compounded semaglutide, a Wegovy knockoff, amid shortages
Note any concerning symptoms to discuss at follow-up appointments
Ro, Hims & Midi The GLP-1 economy now divides direct-to-consumer platforms (Ro, Hims) built for customer acquisition and prescription throughput from emerging care platforms (Knownwell, Midi) built for insurer acceptance and longitudinal management
DOT testing uses the federal 5-panel exclusively
It plays a crucial role in controlling your appetite and insulin secretion
( 2 ) For people struggling with obesity or excess weight, these effects can lead to: Reduced appetite and cravings Eating smaller portion sizes without feeling deprived More stable blood sugar, which can help curb energy crashes A gradual, steady loss of body fat over time While GLP-1 medications were first approved for diabetes management, researchers soon noticed that many patients taking the medication experienced significant weight loss as a side effect
